Navigation Links
EURO in Biological Technology

Index Ventures Closes Euro 350 Million Early Stage Fund

Ben Holmes Named Partner LONDON, March 3 /PRNewswire/ -- Index Ventures today announced the closing of a euro 350 million early stage fund, Index Ventures V. The fund is dedicated to early stage and seed investments in the technology, biotechnology and clean technology sectors across Europ...

AFFiRiS - MIG-Fonds Increases Investment by Euro 3 Million

VIENNA, Austria, September 25 /PRNewswire/ -- The successful progress of several vaccine programmes run by AFFiRiS GmbH has prompted investor MIG AG to increase its investment in the company. It has set up two new funds - MIG 5 and MIG 7 - to give private investors in Germany and Austria the o...

TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm

NEW YORK, MUNICH, Germany and AMSTERDAM, Netherlands, Aug. 21 /PRNewswire/ -- Paul Capital Healthcare and SpePharm Holding, B.V., the pan-European specialty pharmaceutical company, today announced that they have entered into a euro 10 million revenue interest acquisition financing agreement to...

Vernalis and Paul Capital Healthcare Sign euro 18.4 Million Financing Agreement

NEW YORK and WINNERSH, England, April 21 /PRNewswire/ -- Paul Capital Healthcare and Vernalis plc (LSE: VER) today announced that they have signed a financing agreement relating to frovatriptan, Vernalis' product for the treatment of migraine. Under the agreement, Vernalis will receive approxi...

Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance

EATONTOWN, N.J., April 18 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE ), a leader in the emerging field of biologic solutions for regenerative medicine, announced today that it has renewed its exclusive tissue recovery agreement with The Euro Atlantic Transplant Alliance ("EATA"),...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

...n the following exchange rate scenarios, which are not forecasts, the impact on our base guidance would be: euro fx GBP fx Non GAAP diluted rate rate earnings per ADS ...

Sanofi-aventis Announces Second Quarter 2009 Results

...---- ------- ------- ------- Net euro euro sales 7,... net income excluding selected euro euro items 2,...Adjusted EPS excluding selected euro euro items 1...

American Mothers Seriously Concerned About Childhood Allergies, Siemens Survey Reveals

...8 (Sept. 30), Siemens Healthcare reported sales of euro 11.2 billion, orders of euro 11.8 billion, and Sector profit of euro 1.2 billion. Further information can be found by v...

Essilor : First Half 2009 Revenue

...ve currency effect was mainly due to the US dollar's 15.4% gain against the euro during the period. On the downside, reported revenue was reduced by the declines against the euro in the British pound (down 12.4%), the Brazilian real (down 10.9%) and the ...

Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain

... Global Market. A non-profit Foundation, jointly sponsored by ROVI and the Spanish authorities, will be formed and initially funded with a 25 million euro credit line from the Spanish government, to support Phase III clinical development and other studies necessary to achieve marketing authorization of t...

Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals

..., the leading provider of automated micro-immunoassays for therapeutic protein development, announces that it has raised SEK 80 million (approximately euro 7.5 million) in an equity fundraising led by SLS Invest, the Company's leading shareholder. The new funds will enable Gyros to drive the further comme...

AFFiRiS AG: 1st Place in Venture Capital & Private Equity Awards for MIG Fonds and AFFiRiS

...e years ago MIG Fonds started to invest a total of euro 11.5 million. Without this capital, our licensing ...uld not have been possible. This deal is for up to euro 430 million in upfront and milestone payments for ... anticipates milestone-dependent payments of up to euro 430 million. AFFiRiS currently employs 50 highly q...

Cappella Inc. Secures $17.3 Million Series C Investment

...unched its inaugural fund (Fountain Healthcare Partners I) in May 2008 with euro 75M in committed capital. www.fh-partners.com About Mitsui & ...tal firms. Founded as an independent operation in 1994, ACT has raised over euro 350m for investment in growing Irish companies, sourced from American, Euro...

Monsanto, BASF Scientists Disclose Discovery of Gene Conferring Drought Tolerance in Corn Plants

...ant role in finding answers to global challenges such as climate protection, energy efficiency, nutrition and mobility. BASF posted sales of more than euro 62 billion in 2008 and had approximately 97,000 employees as of the end of the year. BASF shares are traded on the stock exchanges in Frankfurt (BAS),...

BASF Sues DuPont for Patent Infringement

...allenges, such as climate protection, energy efficiency, nutrition and mobility. BASF has approximately 97,000 employees and posted sales of more than euro 62 billion in 2008. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). Further information on BASF is ava...

Vimpat(R) (lacosamide) C-V, a New Antiepileptic Drug (AED), To Be Available in U.S. Pharmacies

...fields of central nervous system and immunology disorders. Employing more than 10,000 people in over 40 countries, UCB achieved revenue of 3.6 billion euro in 2008. UCB is listed on Euronext Brussels (symbol: UCB). Forward looking statement This press release contains forward-looking state...

Disability and Poor Quality of Life Associated With Treatment Failure Gout Patients

...SVNT - G Contact: Mary Coleman Savient Pharmaceuticals, Inc. information@savient.com (732) 418-9300 Christina Gibson euro RSCG Life Worldwide christina.gibson@eurorscg.com (212) 367-6818 ...

Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young

...enues of European public biotechs increased 17% to euro 11.2 billion. Capital raised by European biotechs fell from euro 5.5 billion in 2007 to less than euro 2 billion in 2008. Asia-Pacific...

Shire begins the year with a strong performance

...d on the following exchange rate scenarios, which are not forecasts, the impact on our base guidance would be: euro fx GBP fx Non GAAP diluted rate rate earnings per ADS ...

ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG

...8 (Sept. 30), Siemens Healthcare reported sales of euro 11.2 billion, orders of euro 11.8 billion, and Sector profit of euro 1.2 billion. Further information can be found by v...

Siemens Healthcare Announces Planned Collaboration with Harris Corporation

...8 (Sept. 30), Siemens Healthcare reported sales of euro 11.2 billion, orders of euro 11.8 billion, and Sector profit of euro 1.2 billion. Further information can be found by v...

Siemens Showcases New Hearing Loss Solutions at AudiologyNOW! Conference

...8 (Sept. 30), Siemens Healthcare reported sales of euro 11.2 billion, orders of euro 11.8 billion, and Sector profit of euro 1.2 billion. Further information can be found by v...

Nuevolution Announces Progress in Its Collaboration With Merck & Co. Inc.

...address major unmet medical needs across a range of therapeutic areas and target classes. Nuevolution is a privately owned company and has raised euro 37 million in financing from key Scandinavian investors, including SEB Venture, Sunstone Capital, SLS Venture and Novo A/S. For more information about...

Roche to Introduce New LightCycler(R) MRSA Advanced Test in the EU

...stimated that infections such as MRSA kill 5,000 people each year in the UK and hospital-associated infections cost the National Health Service around euro 1 billion a year.(ii) About the LightCycler(R) System With more than 6,600 LightCycler(R) Instruments in the market today, the LightCycler(R)...

BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth

...hallenges such as climate protection, energy efficiency, nutrition and mobility. BASF has approximately 97,000 employees and posted sales of more than euro 62 billion in 2008. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). Further information on BAS...

Siemens Focuses on Role-Based, Context-Sensitive, and Knowledge-Driven Solutions at HIMSS 2009

...7 (Sept. 30), Siemens Healthcare reported sales of euro 9.85 billion, orders of euro 10.27 billion, and group profit of euro 1.32 billion. Further information can be found by ...

IDM Pharma Reports 2008 Financial Results

...r value of warrants issued in February and June 2007. The foreign exchange gain, which results from changes in the value of the dollar versus the euro on the dollar denominated inter-company loan between the Company's subsidiaries, was $0.1 million in the fourth quarter of 2008, compared to a foreign...

Helix BioPharma Announces Q2 2009 Financial Results

...ation of the Company's integrated foreign operation in Ireland. The net assets in Ireland consist mainly of cash and cash equivalents, denominated in euro dollars, which are used to fund clinical trials of Topical Interferon Alpha-2b in Europe. In addition, U.S. dollar purchases of inventory for distrib...

Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin'

... central nervous system and immunology disorders. Employing approximately 12,000 people in more than 40 countries, UCB achieved revenue of 3.6 billion euro in 2007. UCB is listed on NYSE Euronext (symbol: UCB). Worldwide headquarters is located in Brussels, Belgium; U.S. headquarters is located in Atlanta...

Amsterdam Molecular Therapeutics Reports Full Year Results 2008

...2008, AMT had cash and cash equivalents of EUR 34.2 million, compared to EUR 51.3 million at December 31, 2007. The cash burn for the year amounted to euro 17.2 million which is in line with the guidance AMT has given for 2008. "Despite the setback in the filing date for AMT's lead product GlyberaT...

Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008

...riod, a decrease of $26.9 million. This decrease is driven by the effects of foreign currency translation, primarily reflecting the weakening of the euro versus the U.S. dollar, as revenues in local currencies were higher in the current year. Strong year-over-year growth was experienced in two of the c...

Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion

...ements during 2009, but based on the following exchange rate scenarios the impact on our base guidance would be: euro fx GBP fx Non GAAP diluted rate rate earnings per ADS ...

Following a Record Year in 2008 Gerresheimer Again Sets its Sights on Substantial Growth in 2009

...ELDORF, Germany, February 17 /PRNewswire/ -- - Sales Grow by 10.7% to EUR1.06bn - Adjusted Earnings per Share Improves by 36.6% From EUR1.34 euro to EUR1.83 - Adjusted EBITDA Margin Rises From 19.0 to 19.5% - CEO Dr. Axel Herberg: "Following the record year in 2008 Gerresheimer ...

ExL Pharma Presents The Pharmaceutical Managed Markets Insight & Marketing for the Pharmaceutical Industry Conference

...ice president and managed markets practice leader, euro RSCG Life, will be discussing insights and strateg...al needs of the healthcare community. About euro RSCG Life: euro RSCG Life aligns the company's 50 health-focused o...

Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results

...inues to be a concern and the deterioration of the euro has adversely impacted our Angio-Seal royalties in...ompany had previously assumed a U.S. Dollar to the euro exchange rate of 1.44 for the second quarter perio...revious guidance estimated that the U.S. Dollar to euro exchange rate would average 1.44, but the Company ...

bioMerieux Introduces Surveillance Tool to Fight Healthcare-Associated Infections

...stics for over 45 years, bioMerieux is present in 150 countries through 39 subsidiaries and a large network of distributors. In 2008, revenues reached euro 1.111 billion with 84% of sales outside of France. bioMerieux provides diagnostic solutions (reagents, instruments, software) that determine th...

BASF and Monsanto Formalize Agreement to Develop Dicamba-Based Formulation Technologies

...nto, see http://www.monsanto.com . About BASF With sales of euro 3,137 million in 2007, BASF's Crop Protection division is a leader in crop ...nd mobility. BASF has more than 95,000 employees and posted sales of almost euro 58 billion in 2007. BASF shares are traded on the stock exchanges in Frankf...

Combating infection of crops by nematodes is soon to improve

...ruit. Severely infected plants often do not survive the damage that the worms inflict. Each year, plant-parasitic nematodes cause more than 80 billion euro in agricultural losses worldwide. Plant roots as food factories Some of these nematodes have developed an ingenious way of making a plant feed ...

Micromet Enters Into Agreement for Solid Tumor BiTE Antibody with Bayer Schering Pharma AG

...Under the terms of the agreement, Bayer Schering Pharma will pay Micromet a euro 4.5 million fee (approx. US$ 6 million) to secure a one year option on a sp...ould be eligible for an option exercise fee and milestone payments of up to euro 290 million (approx. US$ 390 million) in total and up to double digit royal...

Laboratory Customers Name bioMerieux 'Top Of Class' for Microbiology

...over 45 years, bioMerieux is present in more than 150 countries through 39 subsidiaries and a large network of distributors. In 2007, revenues reached euro 1.063 billion with 84% of sales outside of France. bioMerieux provides diagnostic solutions (reagents, instruments, software) which determine ...
Other Tags
(Date:9/19/2014)... new study shows that legume plants regulate their ... molecules that are transmitted through the plant structure ... number of bacteria-holding nodules in the roots. This ... National Institute for Basic Biology, the Graduate University ... for Sustainable Resource Science in Japan. , ...
(Date:9/18/2014)... 18, 2014 New research into the Crimean-Congo hemorrhagic ... severe hemorrhagic disease in humans similar to that caused ... CCHFV infection. This discovery has the potential to lead ... , The research, reported in a paper ... and conducted by scientists at the Texas Biomedical Research ...
(Date:9/18/2014)... The fall foliage season that prompts millions of Americans to ... later and possibly last a little longer within a century, ... leaf peeping in some areas of the United States as ... report in the journal Global Ecology and Biogeography . ... that is the state tree of New Hampshire could ...
Breaking Biology News(10 mins):For legume plants, a new route from shoot to root 2Research milestone in CCHF virus could help identify new treatments 2Fall foliage season may be later, but longer on warmer Earth 2Fall foliage season may be later, but longer on warmer Earth 3Fall foliage season may be later, but longer on warmer Earth 4
(Date:9/19/2014)... “Copay coupons,” a drug manufacturer marketing ... among patients with prescription drug coverage, may now be ... report from the Department of Health and Human ... laws prohibit suppliers from offering side-payments to increase sales ... , The report highlights that two recent surveys, including ...
(Date:9/19/2014)... Unbound , an international humanitarian organization based ... the Philippines being affected by both a tropical storm and ... to the nearest public schools while others moved to higher ... winds to portions of the northern Philippines. , The ... with more than 10 feet of water. , “It ...
(Date:9/19/2014)... FRIDAY, Sept. 19, 2014 (HealthDay News) -- As kids ... the targets of cyberbullies, according to a recent study. ... grades 5 through 8 found that verbal and physical ... patterns vary, bullying intervention and prevention strategies must address ... bullying among boys and girls, the researchers said. The ...
(Date:9/19/2014)... of human cancers have abnormally upregulated chemical signals ... are controlled during tumor formation is not fully ... Fayngerts, PhD, both researchers in the department of ... of Medicine, University of Pennsylvania, and colleagues report ... cancer by targeting these pathways. , Lipid second ...
(Date:9/19/2014)... (Lebanon, NH 9/18/14) A leading Dartmouth researcher, working with ... co-authored a paper published today in the Journal ... telomeres increase the risk of melanoma. , "For the ... the length of these telomeres play a part in ... the study Mark Iles, PhD, School of Medicine at ...
Breaking Medicine News(10 mins):Health News:PCMA: New OIG Report Cites Drug Manufacturer“Copay Coupon” Use in Medicare Part D 2Health News:Double Threat in Philippines Displaces Thousands of Unbound Families 2Health News: Cyberbullying Seems to Ramp Up in Middle School 2Health News:New cancer drug target involving lipid chemical messengers 2Health News:Melanoma risk found to have genetic determinant 2
Other Contents